165 related articles for article (PubMed ID: 3278821)
21. Systemic and cardiac haemodynamic interactions between guanfacine and hydrallazine in hypertensive patients.
Velasco M; Urbina-Quintana A; Morillo J; Vizcarrondo H; Ramirez A; Hernández E; Hernández-Pieretti O
Eur J Clin Pharmacol; 1984; 27(4):393-6. PubMed ID: 6394347
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of arterial hypertension with a single daily dose of guanfacine].
Jardim PC; Rassi S; Lopes M; Simioni PR; Guimarães E; Maranhão MF; Porto CC
Arq Bras Cardiol; 1984 Nov; 43(5):365-9. PubMed ID: 6399438
[No Abstract] [Full Text] [Related]
23. Elevated plasma catecholamines in hypertensives with primary glomerular diseases.
Ishii M; Ikeda T; Takagi M; Sugimoto T; Atarashi K; Igari T; Uehara Y; Matsuoka H; Hirata Y; Kimura K; Takeda T; Murao S
Hypertension; 1983; 5(4):545-51. PubMed ID: 6345363
[TBL] [Abstract][Full Text] [Related]
24. [Haemodynamic investigations with the new antihypertensive drug guanfacine (author's transl)].
Rosenthal J; Schäfer N; Rauh J; Raschig A
Dtsch Med Wochenschr; 1980 Nov; 105(48):1680-4. PubMed ID: 7002524
[TBL] [Abstract][Full Text] [Related]
25. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
Malini PL; Strocchi E; Ambrosioni E; Magnani B
Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
[TBL] [Abstract][Full Text] [Related]
26. Guanfacine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension.
Sorkin EM; Heel RC
Drugs; 1986 Apr; 31(4):301-36. PubMed ID: 3519177
[TBL] [Abstract][Full Text] [Related]
27. Comparative study of two antihypertensive agents: guanfacine and guanethidine.
Szám I; Kállay K
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):85S-87S. PubMed ID: 6994786
[TBL] [Abstract][Full Text] [Related]
28. Comparison of guanfacine and clonidine as antihypertensive agents.
Jäättelä A
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):67S-70S. PubMed ID: 6994782
[TBL] [Abstract][Full Text] [Related]
29. Guanfacine as monotherapy for systemic hypertension.
Fillingim JM; Blackshear JL; Strauss A; Strauss M
Am J Cardiol; 1986 Mar; 57(9):50E-54E. PubMed ID: 3513531
[TBL] [Abstract][Full Text] [Related]
30. Prolactin, renin, growth hormone, lipoproteins and glucose under guanfacine treatment.
Hauger-Klevene JH; Balossi EC; Scornavacchi JC
Cor Vasa; 1987; 29(4 Suppl 1):17-22. PubMed ID: 3119290
[TBL] [Abstract][Full Text] [Related]
31. Blood pressure and prolactin: effects of guanfacine. Three-year follow-up study.
Hauger-Klevene JH; Pinkas MB; Gerber S
Hypertension; 1981; 3(6 Pt 2):II-222-5. PubMed ID: 7028619
[TBL] [Abstract][Full Text] [Related]
32. [A new antihypertensive agent used in a clinical setting].
Wetzels E; Raschig A; Kaiser HJ
Med Klin; 1980 Sep; 75(19):688-92. PubMed ID: 7001207
[TBL] [Abstract][Full Text] [Related]
33. Improved exercise performance of hypertensive patients treated with guanfacine (Estulic Sandoz).
Bazika V
Cor Vasa; 1987; 29(4 Suppl 1):42-5. PubMed ID: 3315450
[TBL] [Abstract][Full Text] [Related]
34. Guanfacine in essential hypertension: effects during rest and isometric exercise.
Hedner T; Nyberg G; Mellstrand T
Clin Pharmacol Ther; 1984 May; 35(5):604-9. PubMed ID: 6370553
[TBL] [Abstract][Full Text] [Related]
35. Long-term clinical experience with guanfacine.
Fetkovská N; Brimichová G; Sebeková K; Dzúrik R
Cor Vasa; 1987; 29(4 Suppl 1):23-9. PubMed ID: 3315447
[TBL] [Abstract][Full Text] [Related]
36. [Antihypertensive therapy with guanfacine. A multicenter trial with Estulic Wander 1 mg].
Schäfer N; Knaup G
MMW Munch Med Wochenschr; 1982 Mar; 124(10):249-52. PubMed ID: 6806612
[No Abstract] [Full Text] [Related]
37. Hypotensive effect of guanfacine in essential hypertension: a comparison with clonidine.
Lauro R; Reda G; Spallone L; Anguissola AB
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):81S-82S. PubMed ID: 6994784
[No Abstract] [Full Text] [Related]
38. Clinical experience with guanfacine in long-term treatment of hypertension.
Jerie P
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):37S-47S. PubMed ID: 6994777
[No Abstract] [Full Text] [Related]
39. [Hypotensive and hemodynamic effects of guanfacine in arterial hypertension].
Erina EV; Beliakova EV; Charyev KhZ; Panfilov VV
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1989; 12(1):63-7. PubMed ID: 2663029
[TBL] [Abstract][Full Text] [Related]
40. Haemodynamics in hypertensive patients before and during guanfacine treatment.
Schäfer N; Rauh J; Rosenthal J
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):133S-135S. PubMed ID: 6994767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
